About: Research Progress of Coronavirus Based on Bibliometric Analysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Research Progress of Coronavirus Based on Bibliometric Analysis Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Research Progress of Coronavirus Based on Bibliometric Analysis
Creator	Yang, Jing Yang, Jie Cong, Chuang Feng, Tianyi Liang, Jiankun Liang, Zhengxuan Song, Tingyan Xiang, Rongwu Zeng, Ya Zhai, Fei Zhai, Yuxuan
Source	Medline; PMC
abstract	Background: COVID-19 has become one of the most serious global epidemics in the 21st Century. This study aims to explore the distribution of research capabilities of countries, institutions, and researchers, and the hotspots and frontiers of coronavirus research in the past two decades. In it, references for funding support of urgent projects and international cooperation among research institutions are provided. Method: the Web of Science core collection database was used to retrieve the documents related to coronavirus published from 2003 to 2020. Citespace.5.6.R2, VOSviewer1.6.12, and Excel 2016 were used for bibliometric analysis. Results: 11,036 documents were retrieved, of which China and the United States have contributed the most coronavirus studies, Hong Kong University being the top contributor. Regarding journals, the Journal of Virology has contributed the most, while in terms of researchers, Yuen Kwok Yung has made the most contributions. The proportion of documents published by international cooperation has been rising for decades. Vaccines for SARS-CoV-2 are under development, and clinical trials of several drugs are ongoing. Conclusions: international cooperation is an important way to accelerate research progress and achieve success. Developing corresponding vaccines and drugs are the current hotspots and research directions.
has issue date	2020-05-26(xsd:dateTime)
bibo:doi	10.3390/ijerph17113766
bibo:pmid	32466477
has license	cc-by
sha1sum (hex)	8ca5c78ec5f501e6fce3871f35b880fbbad06c64
schema:url	https://doi.org/10.3390/ijerph17113766
resource representing a document's title	Research Progress of Coronavirus Based on Bibliometric Analysis
has PubMed Central identifier	PMC7312058
has PubMed identifier	32466477
schema:publication	Int J Environ Res Public Health
resource representing a document's body	covid:8ca5c78ec5f501e6fce3871f35b880fbbad06c64#body_text
is schema:about of	named entity 'progress' named entity 'documents' named entity 'references' named entity 'clinical trials' named entity 'SARS-CoV-2' named entity 'global' named entity 'documents' named entity 'Italy' named entity 'Century' named entity 'hotspots' named entity 'SARS-CoV-2' named entity 'references' named entity 'support' named entity 'strains' named entity 'emergencies' named entity '2003' named entity 'international cooperation' named entity 'SARS-CoV-2' named entity 'bibliometric analysis' named entity 'SARS-CoV' named entity 'SARS-CoV-2' named entity 'coronavirus' named entity 'cases in the United States' named entity 'United States' named entity 'vaccine' named entity 'lung' named entity 'Germany' named entity 'citation network' named entity 'bibliometric' named entity 'diabetics' named entity 'MERS' named entity 'Egypt' named entity 'China' named entity 'protein structure' named entity 'angiotensin converting enzyme 2' named entity 'Web of Science Core Collection' named entity 'representing the frequency' named entity 'Japan' named entity 'biochemistry' named entity 'molecular biology' named entity 'coronavirus' named entity 'SARS-CoV-2' named entity 'virus' named entity 'coronavirus' named entity 'MERS' named entity 'evolutionary history' named entity 'betweenness centrality' named entity 'European Union' named entity 'vaccine' named entity 'MERS outbreak' named entity 'coronavirus' named entity 'genome' named entity 'SARS-CoV-2' named entity 'Europe' named entity 'coronavirus' named entity 'MERS-CoV' named entity 'washing hands' named entity 'lymphocytopenia' named entity 'Lancet' named entity 'enzyme' named entity 'MERS' named entity 'biosafety' named entity 'betweenness centrality' named entity 'South Korea' named entity 'genetics' named entity 'Microbiology' named entity 'England' named entity 'U.S. National Institutes of Health' named entity 'Vaccines' named entity 'representing the frequency' named entity 'Bibliometric analysis'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software